Racial disparities in infant mortality: a quality of care perspective [0.03%]
种族差异与婴儿死亡率：一个有关医疗质量的视角
Elizabeth A Howell
Elizabeth A Howell
Black infants in the United States are more than twice as likely to die as White infants in the first year of life. Reducing the existing racial disparity in infant mortality rates is a major health policy focus. Despite decades of research...
Understanding reasons for underuse: an approach to improve quality and reduce disparities in breast cancer treatment [0.03%]
了解使用不足的原因：提高乳腺癌治疗质量和减少差异的方法
Nina A Bickell,Alicia Cohen
Nina A Bickell
Objective: Effective adjuvant treatments proven to prolong survival for breast cancer exist, yet many women, particularly minority women, do not receive them. Little work has focused on improving the quality of, and reduc...
A model for using community-based participatory research to address the diabetes epidemic in East Harlem [0.03%]
在东哈莱姆社区开展基于参与式研究的糖尿病防治项目模型
Carol R Horowitz,Judith Z Goldfinger,Sara E Muller et al.
Carol R Horowitz et al.
Objective: Diabetes prevalence and mortality are increasing, with minority populations disproportionately affected. Despite evidence that weight loss due to improved nutrition and increased physical activity can prevent o...
Mark R Chassin,Rebecca M Anderson
Mark R Chassin
Substantial racial and ethnic disparities in health and health care exist in the United States. The Department of Health Policy at the Mount Sinai School of Medicine has developed a strategy for reducing those disparities that builds upon i...
Penny A Asbell
Penny A Asbell
Apparent mineralocorticoid excess manifested in an elderly patient with hypothyroidism [0.03%]
甲状腺功能减退的老年人出现类矿物皮质激素过多症
Maria I New
Maria I New
Fred Rosner
Fred Rosner
Daniel P Perl
Daniel P Perl
Over the years, pathologists have served to make morphologic diagnoses for clinicians when provided with a biopsy or surgically resected tissue specimen. Traditionally, pathologists have used a series of morphologic techniques and relied on...
Erwin P Bottinger
Erwin P Bottinger
Personalized medicine introduces the promise to use molecular markers that signal the risk of disease or its presence before clinical signs and symptoms appear. This information underlies a new healthcare strategy focused on prevention and ...